Miyasaka A - Search Results

1

SEB genotyping: SmartAmp-Eprimer binary code genotyping for complex, highly variable targets applied to HBV.

Delobel D, Furutani Y, Nagoshi S, Tsubota A, Miyasaka A, Watashi K, Wakita T, Matsuura T, Usui K. Delobel D, et al. Among authors: miyasaka a. BMC Infect Dis. 2022 Jun 3;22(1):516. doi: 10.1186/s12879-022-07458-4. BMC Infect Dis. 2022. PMID: 35659601 Free PMC article.

2

[High prevalence of TT virus(TTV) in patients with non A to non G fulminant hepatitis: differences of clinical features and prognosis between TTV positive and negative patients].

Miyasaka A, Suzuki K, Abe K, Iwai M, Takikawa Y, Ishikawa K, Sato S. Miyasaka A, et al. Nihon Rinsho. 1999 Jun;57(6):1339-44. Nihon Rinsho. 1999. PMID: 10390995 Japanese.

3

[The clinical features of HBV asymptomatic carrier, and management].

Miyasaka A, Suzuki K. Miyasaka A, et al. Nihon Rinsho. 2011 May;69 Suppl 4:434-9. Nihon Rinsho. 2011. PMID: 22096957 Japanese. No abstract available.

4

Next-generation sequencing analysis of the human T-cell and B-cell receptor repertoire diversity before and after hepatitis B vaccination.

Miyasaka A, Yoshida Y, Wang T, Takikawa Y. Miyasaka A, et al. Hum Vaccin Immunother. 2019;15(11):2738-2753. doi: 10.1080/21645515.2019.1600987. Epub 2019 Jul 25. Hum Vaccin Immunother. 2019. PMID: 30945971 Free PMC article.

5

[Clinical characteristics of acute non A to G hepatitis caring TTV-DNA].

Abe K, Okano T, Miyasaka A, Sato S, Suzuki K, Sato S, Ishikawa K. Abe K, et al. Among authors: miyasaka a. Nihon Rinsho. 1999 Jun;57(6):1285-9. Nihon Rinsho. 1999. PMID: 10390984 Japanese.

6

Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A.

Sainokami S, Abe K, Kumagai I, Miyasaka A, Endo R, Takikawa Y, Suzuki K, Mizuo H, Sugai Y, Akahane Y, Koizumi Y, Yajima Y, Okamoto H. Sainokami S, et al. Among authors: miyasaka a. J Gastroenterol. 2004 Jul;39(7):640-8. doi: 10.1007/s00535-003-1359-5. J Gastroenterol. 2004. PMID: 15293134

7

Viral decline over 48h and HCV amino acid mutations are related to efficacy of PEG-IFN/ribavirin.

Miyasaka A, Kumagai I, Abe K, Suzuki K. Miyasaka A, et al. Hepatogastroenterology. 2012 May;59(115):794-9. doi: 10.5754/hge11570. Hepatogastroenterology. 2012. PMID: 22020909

8

Hepatitis B Surface Antibody Titers at One and Two Years after Hepatitis B Virus Vaccination in Healthy Young Japanese Adults.

Kakisaka K, Sakai A, Yoshida Y, Miyasaka A, Takahashi F, Sumazaki R, Takikawa Y. Kakisaka K, et al. Among authors: miyasaka a. Intern Med. 2019 Aug 15;58(16):2349-2355. doi: 10.2169/internalmedicine.2231-18. Epub 2019 May 22. Intern Med. 2019. PMID: 31118375 Free PMC article.

9

Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin: A case report and literature review.

Miyasaka A, Yoshida Y, Suzuki A, Masuda T, Okamoto H, Takikawa Y. Miyasaka A, et al. Medicine (Baltimore). 2020 Oct 9;99(41):e22650. doi: 10.1097/MD.0000000000022650. Medicine (Baltimore). 2020. PMID: 33031326 Free PMC article. Review.

10

Fatal acute hepatic failure in a family infected with the hepatitis A virus subgenotype IB: A case report.

Yoshida Y, Okada Y, Suzuki A, Kakisaka K, Miyamoto Y, Miyasaka A, Takikawa Y, Nishizawa T, Okamoto H. Yoshida Y, et al. Among authors: miyasaka a. Medicine (Baltimore). 2017 Sep;96(35):e7847. doi: 10.1097/MD.0000000000007847. Medicine (Baltimore). 2017. PMID: 28858094 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters